Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercator MedicalFRA:MM2 +0.16%58 Days Sales Outstanding is 45.87 as of Jun. 2026, which is 8% below its 10-year median of 49.64. GuruFocus rates FRA:MM2 with a GF Score™ of 58/100 and a GF Value™ of €11.70. The stock has 6 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Mercator Medical ranks better than 58.2% on this metric.
The historical rank and industry rank for Mercator Medical's Days Sales Outstanding or its related term are showing as below:
FRA:MM2'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.03 Med: 49.64 Max: 70.17
Current: 59.41
During the past 13 years, Mercator Medical's highest Days Sales Outstanding was 70.17. The lowest was 17.03. And the median was 49.64.
FRA:MM2's Days Sales Outstanding is ranked better than 58.2% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs FRA:MM2: 59.41
Mercator Medical's Days Sales Outstanding
declined
from Jun. 2025 (60.40) to Jun. 2026 (45.87).
Mercator Medical (FRA:MM2) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Mercator Medical Days Sales Outstanding Related Terms
Mercator Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Mercator Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MM2 vs ISRG, BDX, RMD: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Mercator Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Mercator Medical's Days Sales Outstanding falls into.
Mercator Medical Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercator Medical (FRA:MM2) has a Days Sales Outstanding of 45.87 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mercator Medical and its competitors. This is near median its historical median of 49.64. Over the past decade, Mercator Medical's Days Sales Outstanding has ranged from 17.03 to 70.17. According to the industry distribution chart, Mercator Medical ranks #339 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 41.8%.
Is Mercator Medical's Days Sales Outstanding too high?
Mercator Medical's current Days Sales Outstanding of 45.87 is near median its 10-year median of 49.64. Over the past 10 years, this metric has ranged from a low of 17.03 to a high of 70.17. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Mercator Medical's value of 45.87 is 29.8% below this industry median. Based on the distribution chart, Mercator Medical ranks #339 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mercator Medical has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #339 out of 811 companies for Days Sales Outstanding. This puts Mercator Medical in the upper half of its industry. The industry median Days Sales Outstanding is 65.38. Mercator Medical's value of 45.87 is 29.8% below this benchmark. Historically, Mercator Medical's own Days Sales Outstanding has ranged from 17.03 to 70.17 over the past decade. While the company's 10-year median is 49.64 vs. the industry median of 65.38, Mercator Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current Days Sales Outstanding of 45.87 is 29.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current Days Sales Outstanding is 45.87, which is near median its own 10-year median of 49.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Mercator Medical (FRA:MM2) has a current Days Sales Outstanding of 45.87. The stock's GF Value™ is €11.70, compared to a current price of €12.50 — trading 6.8% above its estimated fair value. The current Days Sales Outstanding is 45.87, which is near median its 10-year median of 49.64 and 29.8% below the Medical Devices & Instruments industry median of 65.38. Mercator Medical's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Days Sales Outstanding is 45.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (FRA:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued.
The current stock price of €12.50 is trading 6.8% above its estimated GF Value™ of €11.70.
Key valuation signals for FRA:MM2:
Days Sales Outstanding: 45.87 (near median its 10-year median of 49.64)
GF Value™: €11.70 vs. price of €12.50 (6.8% above fair value)
Industry Position: 29.8% below the Medical Devices & Instruments median (#339 of 811)
No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
58GF Score
Get the complete analysis for FRA:MM2
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM2 has been successfully added to your 
